A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
2021 · Immunity · 75 citations
https://doi.org/10.1016/j.immuni.2021.08.025
Y
Yuki Anraku
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
829
Citations
11
h-index
11
i10-index
Yuki Anraku is an academic researcher from Hokkaido University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Animal Virus Infections Studies & Viral gastroenteritis research and epidemiology. The author has an h-index of 11, co-authored 20 publications.
ORCID: 0000-0002-5731-0902Papers by this author
worksStructural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
2023 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-39890-8
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1
2024 · Nature Communications · 22 citations
https://doi.org/10.1038/s41467-024-52808-2
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants
2025 · Communications Biology · 1 citations
https://doi.org/10.1038/s42003-025-07827-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat